Skip to main content
. 2020 Nov 19;8:583206. doi: 10.3389/fped.2020.583206

Table 7.

The distribution of samples in the three age groups, depending on prophylactic doses of cholecalciferol.

Doses of cholecalciferol, IU Studies numbers in children 0–3 y.o., n (%) Studies numbers in children 4–10 y.o., n (%) Studies numbers in children 11–18 y.o., n (%)
0 26 (24.3) 87 (44.8) 93 (64.8)
1–1,000 54 (50.5) 60 (30.9) 35 (24.1)
1,001–1,500 18 (16.8) 34 (17.5) 9 (6.2)
≥1,500 9 (8.4) 13 (6.7) 7 (4.8)